APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Smallpox Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Smallpox Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174036250320 December 2025192 pages

Choose your research edition.

Industry ResearchSmallpox Vaccine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Smallpox Vaccine Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Smallpox Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Smallpox Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Smallpox Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Smallpox Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Smallpox Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Smallpox Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Smallpox Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Smallpox Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Smallpox Vaccine include CEL-SCI, Chimerix, EpiVax, Nanotherapeutics, Oncovir, SIGA Technologies, Symphogen, TapImmune and Tonix Pharmaceuticals Holding, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Smallpox Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Smallpox Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Smallpox Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Smallpox Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Smallpox Vaccine Segment by Company

CEL-SCI

Chimerix

EpiVax

Nanotherapeutics

Oncovir

SIGA Technologies

Symphogen

TapImmune

Tonix Pharmaceuticals Holding

Bavarian Nordic

Smallpox Vaccine Segment by Type

First Generation

Second Generation

Third Generation

Smallpox Vaccine Segment by Application

Government Hospital And Program

Private Hospitals / Clinicss

Smallpox Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Smallpox Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Smallpox Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Smallpox Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Smallpox Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Smallpox Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Smallpox Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Smallpox Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Smallpox Vaccine Industry Trends Table 2. Smallpox Vaccine Industry Drivers Table 3. Smallpox Vaccine Industry Opportunities and Challenges Table 4. Smallpox Vaccine Industry Restraints Table 5. Global Smallpox Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Smallpox Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Smallpox Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Smallpox Vaccine Sales Market Share by Manufacturers Table 9. Global Smallpox Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Smallpox Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Smallpox Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Smallpox Vaccine Manufacturers, Product Type & Application Table 13. Global Smallpox Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Smallpox Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of First Generation Table 17. Major Manufacturers of Second Generation Table 18. Major Manufacturers of Third Generation Table 19. Global Smallpox Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Smallpox Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Global Smallpox Vaccine Sales by Type (2027-2032) & (K Units) Table 22. Global Smallpox Vaccine Sales Market Share by Type (2021-2026) Table 23. Global Smallpox Vaccine Sales Market Share by Type (2027-2032) Table 24. Global Smallpox Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Smallpox Vaccine Revenue by Type (2021-2026) & (K Units) Table 26. Global Smallpox Vaccine Revenue by Type (2027-2032) & (K Units) Table 27. Global Smallpox Vaccine Revenue Market Share by Type (2021-2026) Table 28. Global Smallpox Vaccine Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Government Hospital And Program Table 30. Major Manufacturers of Private Hospitals / Clinicss Table 31. Global Smallpox Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Smallpox Vaccine Sales by Application (2021-2026) & (K Units) Table 33. Global Smallpox Vaccine Sales by Application (2027-2032) & (K Units) Table 34. Global Smallpox Vaccine Sales Market Share by Application (2021-2026) Table 35. Global Smallpox Vaccine Sales Market Share by Application (2027-2032) Table 36. Global Smallpox Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Smallpox Vaccine Revenue by Application (2021-2026) & (K Units) Table 38. Global Smallpox Vaccine Revenue by Application (2027-2032) & (K Units) Table 39. Global Smallpox Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global Smallpox Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global Smallpox Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Smallpox Vaccine Sales by Region (2021-2026) & (K Units) Table 43. Global Smallpox Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Smallpox Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Smallpox Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Smallpox Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Smallpox Vaccine Sales by Country (2021-2026) & (K Units) Table 48. North America Smallpox Vaccine Sales by Country (2027-2032) & (K Units) Table 49. Europe Smallpox Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Smallpox Vaccine Sales by Country (2021-2026) & (K Units) Table 51. Europe Smallpox Vaccine Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Smallpox Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Smallpox Vaccine Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Smallpox Vaccine Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Smallpox Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Smallpox Vaccine Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Smallpox Vaccine Sales by Country (2027-2032) & (K Units) Table 58. Global Smallpox Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Smallpox Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Smallpox Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Smallpox Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global Smallpox Vaccine Revenue Market Share by Region (2027-2032) Table 63. CEL-SCI Company Information Table 64. CEL-SCI Business Overview Table 65. CEL-SCI Smallpox Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. CEL-SCI Smallpox Vaccine Product Portfolio Table 67. CEL-SCI Recent Development Table 68. Chimerix Company Information Table 69. Chimerix Business Overview Table 70. Chimerix Smallpox Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Chimerix Smallpox Vaccine Product Portfolio Table 72. Chimerix Recent Development Table 73. EpiVax Company Information Table 74. EpiVax Business Overview Table 75. EpiVax Smallpox Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. EpiVax Smallpox Vaccine Product Portfolio Table 77. EpiVax Recent Development Table 78. Nanotherapeutics Company Information Table 79. Nanotherapeutics Business Overview Table 80. Nanotherapeutics Smallpox Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Nanotherapeutics Smallpox Vaccine Product Portfolio Table 82. Nanotherapeutics Recent Development Table 83. Oncovir Company Information Table 84. Oncovir Business Overview Table 85. Oncovir Smallpox Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Oncovir Smallpox Vaccine Product Portfolio Table 87. Oncovir Recent Development Table 88. SIGA Technologies Company Information Table 89. SIGA Technologies Business Overview Table 90. SIGA Technologies Smallpox Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. SIGA Technologies Smallpox Vaccine Product Portfolio Table 92. SIGA Technologies Recent Development Table 93. Symphogen Company Information Table 94. Symphogen Business Overview Table 95. Symphogen Smallpox Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Symphogen Smallpox Vaccine Product Portfolio Table 97. Symphogen Recent Development Table 98. TapImmune Company Information Table 99. TapImmune Business Overview Table 100. TapImmune Smallpox Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. TapImmune Smallpox Vaccine Product Portfolio Table 102. TapImmune Recent Development Table 103. Tonix Pharmaceuticals Holding Company Information Table 104. Tonix Pharmaceuticals Holding Business Overview Table 105. Tonix Pharmaceuticals Holding Smallpox Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Tonix Pharmaceuticals Holding Smallpox Vaccine Product Portfolio Table 107. Tonix Pharmaceuticals Holding Recent Development Table 108. Bavarian Nordic Company Information Table 109. Bavarian Nordic Business Overview Table 110. Bavarian Nordic Smallpox Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Bavarian Nordic Smallpox Vaccine Product Portfolio Table 112. Bavarian Nordic Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Smallpox Vaccine Distributors List Table 116. Smallpox Vaccine Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Smallpox Vaccine Product Image Figure 2. Global Smallpox Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Smallpox Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Smallpox Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Smallpox Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Smallpox Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. First Generation Image Figure 9. Second Generation Image Figure 10. Third Generation Image Figure 11. Global Smallpox Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Smallpox Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Smallpox Vaccine Sales Market Share by Type (2021-2032) Figure 14. Global Smallpox Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Smallpox Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Smallpox Vaccine Revenue Market Share by Type (2021-2032) Figure 17. Government Hospital And Program Image Figure 18. Private Hospitals / Clinicss Image Figure 19. Global Smallpox Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Smallpox Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Smallpox Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global Smallpox Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Smallpox Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Smallpox Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Smallpox Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Smallpox Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Smallpox Vaccine Sales Market Share by Country (2021-2032) Figure 39. China Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Smallpox Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Smallpox Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Smallpox Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Smallpox Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Smallpox Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America Smallpox Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Smallpox Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Smallpox Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Smallpox Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Smallpox Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Smallpox Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Smallpox Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Smallpox Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Smallpox Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • First Generation
  • Second Generation
  • Third Generation
Applications
  • Government Hospital And Program
  • Private Hospitals / Clinicss
Companies covered
  • CEL-SCI
  • Chimerix
  • EpiVax
  • Nanotherapeutics
  • Oncovir
  • SIGA Technologies
  • Symphogen
  • TapImmune
  • Tonix Pharmaceuticals Holding
  • Bavarian Nordic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Smallpox Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Smallpox Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Smallpox Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Smallpox Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Smallpox Vaccine Market Dynamics
  1. 2.1 Smallpox Vaccine Industry Trends
  2. 2.2 Smallpox Vaccine Industry Drivers
  3. 2.3 Smallpox Vaccine Industry Opportunities and Challenges
  4. 2.4 Smallpox Vaccine Industry Restraints
3 Smallpox Vaccine Market by Manufacturers
  1. 3.1 Global Smallpox Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Smallpox Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Smallpox Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Smallpox Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Smallpox Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Smallpox Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Smallpox Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Smallpox Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Smallpox Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Smallpox Vaccine Tier 1, Tier 2, and Tier 3
4 Smallpox Vaccine Market by Type
  1. 4.1 Smallpox Vaccine Type Introduction
  2. 4.1.1 First Generation
  3. 4.1.2 Second Generation
  4. 4.1.3 Third Generation
  5. 4.2 Global Smallpox Vaccine Sales by Type
  6. 4.2.1 Global Smallpox Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Smallpox Vaccine Sales by Type (2021-2032)
  8. 4.2.3 Global Smallpox Vaccine Sales Market Share by Type (2021-2032)
  9. 4.3 Global Smallpox Vaccine Revenue by Type
  10. 4.3.1 Global Smallpox Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Smallpox Vaccine Revenue by Type (2021-2032)
  12. 4.3.3 Global Smallpox Vaccine Revenue Market Share by Type (2021-2032)
5 Smallpox Vaccine Market by Application
  1. 5.1 Smallpox Vaccine Application Introduction
  2. 5.1.1 Government Hospital And Program
  3. 5.1.2 Private Hospitals / Clinicss
  4. 5.2 Global Smallpox Vaccine Sales by Application
  5. 5.2.1 Global Smallpox Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Smallpox Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Smallpox Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Smallpox Vaccine Revenue by Application
  9. 5.3.1 Global Smallpox Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Smallpox Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Smallpox Vaccine Revenue Market Share by Application (2021-2032)
6 Global Smallpox Vaccine Sales by Region
  1. 6.1 Global Smallpox Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Smallpox Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Smallpox Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Smallpox Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Smallpox Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Smallpox Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Smallpox Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Smallpox Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Smallpox Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Smallpox Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Smallpox Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Smallpox Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Smallpox Vaccine Revenue by Region
  1. 7.1 Global Smallpox Vaccine Revenue by Region
  2. 7.1.1 Global Smallpox Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Smallpox Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Smallpox Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Smallpox Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Smallpox Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Smallpox Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Smallpox Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Smallpox Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Smallpox Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Smallpox Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Smallpox Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Smallpox Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CEL-SCI
  2. 8.1.1 CEL-SCI Company Information
  3. 8.1.2 CEL-SCI Business Overview
  4. 8.1.3 CEL-SCI Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CEL-SCI Smallpox Vaccine Product Portfolio
  6. 8.1.5 CEL-SCI Recent Developments
  7. 8.2 Chimerix
  8. 8.2.1 Chimerix Company Information
  9. 8.2.2 Chimerix Business Overview
  10. 8.2.3 Chimerix Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Chimerix Smallpox Vaccine Product Portfolio
  12. 8.2.5 Chimerix Recent Developments
  13. 8.3 EpiVax
  14. 8.3.1 EpiVax Company Information
  15. 8.3.2 EpiVax Business Overview
  16. 8.3.3 EpiVax Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 EpiVax Smallpox Vaccine Product Portfolio
  18. 8.3.5 EpiVax Recent Developments
  19. 8.4 Nanotherapeutics
  20. 8.4.1 Nanotherapeutics Company Information
  21. 8.4.2 Nanotherapeutics Business Overview
  22. 8.4.3 Nanotherapeutics Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nanotherapeutics Smallpox Vaccine Product Portfolio
  24. 8.4.5 Nanotherapeutics Recent Developments
  25. 8.5 Oncovir
  26. 8.5.1 Oncovir Company Information
  27. 8.5.2 Oncovir Business Overview
  28. 8.5.3 Oncovir Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Oncovir Smallpox Vaccine Product Portfolio
  30. 8.5.5 Oncovir Recent Developments
  31. 8.6 SIGA Technologies
  32. 8.6.1 SIGA Technologies Company Information
  33. 8.6.2 SIGA Technologies Business Overview
  34. 8.6.3 SIGA Technologies Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SIGA Technologies Smallpox Vaccine Product Portfolio
  36. 8.6.5 SIGA Technologies Recent Developments
  37. 8.7 Symphogen
  38. 8.7.1 Symphogen Company Information
  39. 8.7.2 Symphogen Business Overview
  40. 8.7.3 Symphogen Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Symphogen Smallpox Vaccine Product Portfolio
  42. 8.7.5 Symphogen Recent Developments
  43. 8.8 TapImmune
  44. 8.8.1 TapImmune Company Information
  45. 8.8.2 TapImmune Business Overview
  46. 8.8.3 TapImmune Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 TapImmune Smallpox Vaccine Product Portfolio
  48. 8.8.5 TapImmune Recent Developments
  49. 8.9 Tonix Pharmaceuticals Holding
  50. 8.9.1 Tonix Pharmaceuticals Holding Company Information
  51. 8.9.2 Tonix Pharmaceuticals Holding Business Overview
  52. 8.9.3 Tonix Pharmaceuticals Holding Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Tonix Pharmaceuticals Holding Smallpox Vaccine Product Portfolio
  54. 8.9.5 Tonix Pharmaceuticals Holding Recent Developments
  55. 8.10 Bavarian Nordic
  56. 8.10.1 Bavarian Nordic Company Information
  57. 8.10.2 Bavarian Nordic Business Overview
  58. 8.10.3 Bavarian Nordic Smallpox Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bavarian Nordic Smallpox Vaccine Product Portfolio
  60. 8.10.5 Bavarian Nordic Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Smallpox Vaccine Value Chain Analysis
  2. 9.1.1 Smallpox Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Smallpox Vaccine Production Mode & Process
  6. 9.2 Smallpox Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Smallpox Vaccine Distributors
  9. 9.2.3 Smallpox Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst